Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Toxikon Corporation, a contract research organization delivering best-in-class nonclinical testing services.
Toxikon is a Massachusetts-based company that provides analytical testing services for the pharmaceutical, biotechnology, and medical device industries.